[1] |
Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol, 2011; 8, 30-41. doi: 10.1038/nrcardio.2010.165 |
[2] |
Shah AS, Langrish JP, Nair H, et al. Global association of air pollution and heart failure:a systematic review and meta-analysis. Lancet, 2013; 382, 1039-48. doi: 10.1016/S0140-6736(13)60898-3 |
[3] |
Li Q, Morimoto K, Nakadai A, et al. Forest bathing enhances human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmaco, 2007; 20, 3-8. doi: 10.1177/03946320070200S202 |
[4] |
Mao GX, Lan XG, Cao YB, et al. Effects of short-term forest bathing on human health in a broad-leaved evergreen forest in Zhejiang Province, China. Biomed Environ Sci, 2012; 25, 317-24. http://www.sciencedirect.com/science/article/pii/S0895398812600610 |
[5] |
Mao GX, Cao YB, Lan XG, et al. Therapeutic effect of forest bathing on human hypertension in the elderly. J Cardiol, 2012; 60, 495-502. doi: 10.1016/j.jjcc.2012.08.003 |
[6] |
Jia BB, Yang ZX, Mao GX, et al. Health Effect of Forest Bathing Trip on Elderly Patients with Chronic Obstructive Pulmonary Disease, Biomed Environ Sci, 2016; 29, 212-8. |
[7] |
Mao GX, Cao YB, Wang BZ, et al. The salutary influence of Forest bathing on elderly patients with chronic heart failure. Int J Environ Res Public Health, 2017; 14, E368. doi: 10.3390/ijerph14040368 |
[8] |
Ideno Y, Hayashi K, Abe Y, et al. Blood pressure-lowering effect of Shinrin-yoku (Forest bathing):a systematic review and meta-analysis. BMC Complement Altern Med, 2017; 17, 409. doi: 10.1186/s12906-017-1912-z |
[9] |
Hansen MM, Jones R, Tocchini K. Shinrin-Yoku (Forest Bathing) and Nature Therapy:A State-of-the-Art Review. Int J Environ Res Public Health, 2017; 14, E851. doi: 10.3390/ijerph14080851 |
[10] |
Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients withheart failure enrolled in Val-HeFT. Eur Heart J, 2004; 25, 292-9. doi: 10.1016/j.ehj.2003.10.030 |
[11] |
Gutierrez A, Van Wagoner DR. Oxidant and inflammatory mechanisms and targeted therapy in atrial fibrillation:An update. J Cardiovasc Pharmacol, 2015; 66, 523-9. doi: 10.1097/FJC.0000000000000313 |